Fuse Medical Partners on Commercialization of Orbitum Staple

By Julie A. Vetalice

Fuse Medical Partners on Commercialization of Orbitum Staple

Fuse Medical partnered exclusively with Orthovestments for manufacturing and commercialization of the Orbitum™ Staple System in the U.S. Initial launch is slated for 2Q21.

Orbitum is indicated for use in the foot or hand. The titanium alloy implant is novel in shape, with multiple narrow legs arranged in a radius around a central bridge. This leg geometry, comprising multiple narrow tines on the inferior aspect of the implant, increases the surface area of the device. These differentiators have shown to be helpful when space is limited, or if used in cancellous bone, or in cases of soft bone density.

A templating system supports visual confirmation of size and orientation prior to implant placement. The leg geometry provides pull-out resistance five times greater than comparable staples.

Christopher C. Reeg, Chief Executive Officer of Fuse, said, “While there are many staples on the market, we believe that Orbitum offers a novel compression mechanism relying on physics rather than the elasticity of memory metal alloys and eliminates the concern for patients with nickel allergies.”

Product Labels: Trauma Ankle/Foot/Toe, Upper Extremity, Lower Extremity